Applications of Molecular Pathology and the Diagnosis of Soft Tissue Neoplasms


In this month’s “Virtual Lecture,” Andrew Folpe, M.D., discusses applications of molecular pathology and the diagnosis of soft tissue neoplasms. This presentation is applicable for pathologists because so much of what is done in pathology and in sarcoma care is multidisciplinary making it important to understand what others are doing.


Length of Video: 58 minutes


Andrew Folpe, M.D.

Professor of Laboratory Medicine and Pathology
Division of Anatomic Pathology
Mayo Clinic, Rochester, Minnesota

Learning objectives

Upon completion of this activity, participants should be able to:

  • Define the diagnostic approach to a soft tissue neoplasm.
  • Identify the impact of advances in molecular pathology on soft tissue pathology.
  • Recognize the continued role of morphologic evaluation in the era of molecular diagnostics.

Intended audience

This program is appropriate for clinicians, pathologists, medical technologists, nurses, pharmacists, and other allied health staff.


The following types of credit are offered for this event:


Mayo Clinic Laboratories is approved as a provider of continuing education programs in the Clinical Laboratory Sciences by the ASCLS P.A.C.E.® program. This program has been approved for a maximum of 1.0 P.A.C.E.® contact hour.

State of Florida

Mayo Clinic Laboratories is approved as a Continuing Education Accrediting Agency for the Clinical Laboratory Sciences for the State of Florida. Florida Board of Clinical Laboratory Personnel has designated this program for General (Molecular Pathology) credit. This program has been approved for 1.0 contact hour.

To obtain credit

1. Watch the video.

2. Complete the post-test and evaluation that launches immediately following the video.

3. Generate and print your certificate(s).

Level of instruction for this program is advanced.

Credit for this program expires on 3/22/2025.

Faculty disclosure

Course director(s), planning committee, faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty members also will disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentations. Disclosure of this information will be published in course materials so those participants in the activity may formulate their own judgments regarding the presentations.


Contact us:

MCL Education

This post was developed by our Education and Technical Publications Team.